SMARCB1 and rhabdoid tumor: Gene set enrichment analysis (GSEA) demonstrated that gene programs, which are deregulated by loss of SMARCB1 in rhabdoid tumors (MYC, cyclin D1 and the pluripotency program) are further upregulatedfollowing SAHA treatment.